Concepedia

Michelle Busch

MB

Statistics

Publications

9

Citations

399

H-Index

9

Active since

2012

Affiliations

Sanofi (United States)(Current)

Amgen (United States)

Evotec (United States)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Agilent Technologies (United States)

Michelle Busch is an author at Sanofi (United States) specializing in pharmacy, antibody conjugates, and antibody conjugation.

ORCID

Publications per year

2012–2022

9

Publications

9

Site-Specific Antibody–Drug Conjugation through Glycoengineering

Qun Zhou, James E. Stefano, Charlene Manning et al. · Bioconjugate Chemistry · 2014 · 218 citations

, , +17

New Peak Detection Performance Metrics from the MAM Consortium Interlaboratory Study

Trina Mouchahoir, John E. Schiel, Rich Rogers et al. · Journal of the American Society for Mass Spectrometry · 2021 · 41 citations · Full text

, , +17

Targeting HER2-positive cancer with dolastatin 15 derivatives conjugated to trastuzumab, novel antibody–drug conjugates

Diego A. Gianolio, Cécile Rouleau, William E. Bauta et al. · Cancer Chemotherapy and Pharmacology · 2012 · 33 citations

, , +16

Identification and quantitation of vesivirus 2117 particles in bioreactor fluids from infected Chinese hamster ovary cell cultures

Yongchang Qiu, Nathan Jones, Michelle Busch et al. · Biotechnology and Bioengineering · 2012 · 30 citations

, , +17

Design, Synthesis, and in vitro Evaluation of Multivalent Drug Linkers for High‐Drug‐Load Antibody–Drug Conjugates

Bo Chen, Diego A. Gianolio, James E. Stefano et al. · ChemMedChem · 2018 · 16 citations

, , +17

1–5 of 9